- The Trump administration has reclassified cannabis from a Schedule I to a Schedule III substance under the US Controlled Substances Act.
- This change, announced on Thursday, marks a significant shift in federal drug policy, as reported by The Associated Press.
- The reclassification paves the way for the Food and Drug Administration (FDA) to further study cannabis's medicinal uses.
- According to CNN, this move acknowledges the potential medical benefits of cannabis and its lower abuse risk compared to Schedule I drugs.
- Reuters noted that despite the reclassification, marijuana is not legalized for recreational or medical use under federal law.
Cannabis Reclassified to Schedule III
Summarized by Catamist’s AI from other outlets’ reporting and checked for neutrality. Original sources are linked below.
In a historic shift, the Trump administration has reclassified cannabis from a Schedule I to a Schedule III substance under federal law, acknowledging its potential medical benefits and lower abuse risk. While this paves the way for increased FDA research into its medicinal uses, it's crucial to note that marijuana remains federally illegal.
How this was made: Catamist’s AI summarized this story from reporting by other outlets and checked it for neutral, plain-language framing. It is a news summary, not original reporting — the original sources are linked above.
Report an issue with this article
Please sign in to report issues with this article.
Live discussion about this article
Comments
Comments are disabled for this article.
